Superinvestor Tracker
All Investors

Enliven Therapeutics Inc - US

Holders

0

Combined Value

$0

Combined Shares

0

Held By

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of

No tracked investors currently hold this security.

Recent Activity

QuarterInvestorActionEst. ValueEst. Price
Q4 2024Paul Tudor Jones - Tudor InvestmentSOLD OUT−$242K~$25.54
Q3 2024Paul Tudor Jones - Tudor InvestmentNEW BUY+$242K~$25.54

Ownership History

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q3 202419,506$242K$25.54